Regeneron Pharmaceuticals (REGN) Shares Outstanding (2009 - 2026)

Regeneron Pharmaceuticals has reported Shares Outstanding for 18 years, with the latest figure at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.0% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (changed 0.0% YoY), and the FY2025 full-year result was $1.8 million, changed 0.0% from the prior year.
• Shares Outstanding for Q1 2026 stood at $1.8 million, roughly flat from $1.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $136.1 million in Q1 2025, with the low at $1.8 million in Q2 2022.
• Average Shares Outstanding over 5 years is $32.2 million, with a median of $1.8 million recorded in 2022.
• Peak annual rise in Shares Outstanding reached 7466.67% in 2025, while the deepest fall reached 98.66% in 2025.
• Tracing REGN's Shares Outstanding over 5 years: stood at $1.8 million in 2022, then surged by 7294.44% to $133.1 million in 2023, then slumped by 98.65% to $1.8 million in 2024, then changed by 0.0% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
• The last three Shares Outstanding figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $136.2 million (Q3 2025), per Business Quant data.

Peer Comparison